Source: International Congress 2019 – Treatment of asthma with monoclonal antibodies
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
B. Kent (London, United Kingdom), G. D'Ancona (London, United Kingdom), M. Fernandes (London, United Kingdom), L. Green (London, United Kingdom), J. Kavanagh (London, United Kingdom), A. Nanzer-Kelly (London, United Kingdom), C. Roxas (London, United Kingdom), S. Agarwal (London, United Kingdom), D. Jackson (London, United Kingdom). Twelve month outcomes with Reslizumab treatment of Eosinophilic Granulomatosis with Polyangiitis. 1651

Member's Comments

No comment yet.

Related content which might interest you: Eosinophilic granulomatosis with polyangiitis Source: Eur Respir Monogr 2019; 86: 188-209 Year: 2019 Eosinophilic granulomatosis with polyangiitis Source: Eur Respir Monogr 2022; 95: 177-192 Year: 2022 Oral corticosteroid-sparing effects of reslizumab in the treatment of eosinophilic granulomatosis with polyangiitis Source: ERJ Open Res, 6 (1) 00311-2019; 10.1183/23120541.00311-2019 Year: 2020 Asthma follow-up and treatment in a group of 28 patients with eosinophilic granulomatosis with polyangiitis (EGPA) Source: Annual Congress 2013 –Is it really asthma? Year: 2013 Fatal haemoptysis in a case of lymphomatoid granulomatosis treated with rituximab Source: Eur Respir J 2006; 27: 644-646 Year: 2006 ANCA-negative eosinophilic granulomatosis with polyangiitis (EGPA) relatead to sirolimus-eluting stent Source: International Congress 2015 – Chronic airway disorders: miscellaneous aspects Year: 2015 New biomarkers for early diagnosis of eosinophilic granulomatosis with polyangiitis (EGPA) Source: International Congress 2017 – Techniques to treat asthma Year: 2017 Eosinophilic granulomatosis with polyangiitis (formerly Churg–Strauss syndrome): where are we now? Source: Eur Respir J 2015; 46: 1255-1258 Year: 2015 Steroid-sparing effects of benralizumab in patients with eosinophilic granulomatosis with polyangiitis Source: ERJ Open Res, 6 (4) 00451-2020; 10.1183/23120541.00451-2020 Year: 2020 Necrotising sarcoid granulomatosis: clinical, functional, endoscopical and radiographical evaluations Source: Eur Respir J 2005; 26: 778-785 Year: 2005 Frequency of eosinophilic granulomatosis with polyangiitis in Europe by meta-analysis Source: Virtual Congress 2020 – Prevalence and incidence of chronic lung diseases Year: 2020 Lung-limited Granulomatosis with polyangiitis (GPA) managed without immunosuppression Source: International Congress 2018 – CC5 Pulmonary vasculitis: the great chameleon Year: 2018 Relapsing necrotising sarcoid granulomatosis in a young patient Source: Eur Respir J 2007; 29: 816 Year: 2007 Clinical manifestation, approach to diagnosis and treatment of pulmonary vasculitis Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=69 Year: 2005 Granulomatosis with polyangiitis (Wegener&s) Source: Eur Respir Mon 2011; 54: 1-14 Year: 2011 Respiratory manifestations of eosinophilic granulomatosis with polyangiitis (Churg–Strauss) Source: Eur Respir J 2016; 48: 1429-1441 Year: 2016 Biologics for eosinophilic granulomatosis with polyangiitis Source: Short video statement 2020 Year: 2020 Wegener's granulomatosis after Montelukast in patient not receiving systemic steroid treatment Source: Eur Respir J 2002; 20: Suppl. 38, 65s Year: 2002 Pulmonary hypertension as the first manifestation in a patient with granulomatosis with polyangiitis Source: International Congress 2019 – Pulmonary vascular diseases? Year: 2019 Increased Severity of Asthma in Atopic Patients with Eosinophilic Granulomatosis with Polyangiitis Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures Year: 2018